Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study.
Leng X, Lin W, Liu S, Kanik K, Wang C, Wan W, Jiang Z, Liu Y, Liu S, Zhang Z, Zhang Z, Xu J, Tan W, Hu J, Li J, Liu J, Gunay LM, Dina O, Kinch C, Zeng X.
Leng X, et al.
RMD Open. 2023 Jan;9(1):e002559. doi: 10.1136/rmdopen-2022-002559.
RMD Open. 2023.
PMID: 36720560
Free PMC article.
Clinical Trial.